about
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signalingDifferential impact of Toll-like receptor signaling on distinct B cell subpopulationsStructure-Based Design of Novel Human Toll-like Receptor 8 AgonistsNew insights into the enigma of immunoglobulin D.TLR8 deficiency leads to autoimmunity in miceMolecular and cellular signatures of human vaccine adjuvants.Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cellsComplement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation.Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice.Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis.Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.TLR-mediated B cell defects and IFN-α in common variable immunodeficiencyToll-like receptor function in primary B cell defects.Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders.B cell intrinsic TLR signals amplify but are not required for humoral immunity.Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.Immunostimulatory activity of haptenated proteins.Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cellsToll-like receptors: lessons to learn from normal and malignant human B cellsTLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells.Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.Toll-like receptors--sentries in the B-cell response.Modulation of Immune Response Using Engineered Nanoparticle Surfaces.Conceptualizing immune responsiveness.The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock
P2860
Q24684997-208D3CD8-4A77-490D-AA96-8BF80DB62423Q26825241-33BB78DE-4CD6-45C6-B0F7-481C20F50F74Q27681499-3BB71FD6-1037-4DC6-9857-CA04A055D1FDQ27687277-6619987B-ACDC-4629-84BE-DBE6D8030FAAQ28292240-392091E7-F5A5-4476-A565-F756E08914E0Q30370898-24478678-AD65-402E-967D-ADB46DF32EF3Q30537996-E0941874-134D-45F4-95DE-53A9B2D9FA0BQ33302902-87BF51BC-C3EB-4DE7-BCA1-C49676C1D20DQ33378891-95E57370-BBB7-4227-BEE7-A32301267F34Q33964159-2BF450B7-BD8A-4E76-A6A2-E214C67F41E3Q33999768-771444EA-E701-4644-B5E6-5F9222F16071Q34626114-7D8EE259-1F92-4D5F-AC16-DA4BE8599367Q35090905-B0A187FE-E27C-4D2F-BC25-73946B24B0DBQ35679658-CC13FDBD-4091-4F85-A6C2-E17276817646Q36190388-98D4BD56-A39C-4BF1-B48A-647D268AFBBEQ36190430-D4901CA7-ACE8-4CBA-B1CA-E45F2B6EED64Q36232987-53624909-FCDA-453D-8647-C7EB5CFD108FQ36294387-977A8BE1-52BF-4EA5-AD07-5E3E129ACC1EQ37070610-82B3674A-43C7-4DEA-82BD-7C1A373275CFQ37140042-EBA56E61-7EEB-425C-AC1A-E839143B4532Q37152844-741FE3C3-756F-4D48-BE36-203EA54CBE30Q37203723-A278CF41-623D-4E73-BE39-CB505562BE30Q37235039-991EF7C5-54FC-4FF8-9AFC-57A4C2EE318EQ37627725-F3FD78FB-DADF-43D9-92E8-7CCFE01FCCADQ37672658-17E2F1C7-4A06-4DF5-8DED-DC01AB48F300Q38350859-229FBFE5-D0E3-45A7-996F-F4351E7977D8Q38400958-EA03DA93-47E1-4CDA-9196-1515E646C0F5Q38616577-21770C52-C46F-4200-97BC-3C954A50A60CQ38665495-4AAAED54-C06A-4588-A5D7-75B772AA7008Q41940744-F641038A-03FE-4582-99F4-0FDCC23BFFD3Q57109740-3D18F34D-575B-489C-8CFC-3637C0663B4E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunology: Toll-like receptors and antibody responses.
@en
Immunology: Toll-like receptors and antibody responses.
@nl
type
label
Immunology: Toll-like receptors and antibody responses.
@en
Immunology: Toll-like receptors and antibody responses.
@nl
prefLabel
Immunology: Toll-like receptors and antibody responses.
@en
Immunology: Toll-like receptors and antibody responses.
@nl
P2860
P356
P1433
P1476
Immunology: Toll-like receptors and antibody responses.
@en
P2093
P2860
P2888
P304
E4; discussion E4
P356
10.1038/NATURE04875
P407
P577
2006-05-01T00:00:00Z
P6179
1008419842